Analytics

Oct 01, 2017
BioPharm International
A UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
Oct 01, 2017
BioPharm International
Detecting viral contaminants in biologic-based medicines—and identifying their source—requires a holistic testing approach.
Sep 15, 2017
BioPharm International
This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Sep 15, 2017
BioPharm International
A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Sep 14, 2017
Along with particulate control and determination, speakers at the June conference in Rockville, Maryland, examined the role of protein aggregation and immunogenicity
Sep 01, 2017
BioPharm International
The authors review how media components modulate the quality of monoclonal antibody products
Sep 01, 2017
BioPharm International
Choosing a suitable material for fill/finish containers begins during the product development stage.
Aug 14, 2017
By BioPharm International Editors
The expansion at its Lincolnshire, IL, facility will double the footprint of the site’s range of services, including microbiological evaluation, drug stability studies, and medical devices testing.
Aug 01, 2017
BioPharm International
The author outlines an analytical strategy for establishing similarity in biosimilar development and approval.
Aug 01, 2017
BioPharm International
Managing and prioritizing risk is essential to ensuring raw material quality. USP is developing new guidelines to make the work easier.
native1_300x100
lorem ipsum